nach oben

Erschienen in:

01.09.2010 | Article

Differential aetiology and impact of phosphoinositide 3-kinase (PI3K) and Akt signalling in skeletal muscle on in vivo insulin action

verfasst von: M. Friedrichsen, P. Poulsen, E. A. Richter, B. F. Hansen, J. B. Birk, R. Ribel-Madsen, K. Stender-Petersen, E. Nilsson, H. Beck-Nielsen, A. Vaag, J. F. P. Wojtaszewski

Erschienen in: Diabetologia | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Insulin resistance in skeletal muscle is a key factor in the development of type 2 diabetes and although some studies indicate that this could be partly attributed to reduced content and activity of various proximal and distal insulin signalling molecules, consensus is lacking. We therefore aimed to investigate the regulation of proximal insulin signalling in skeletal muscle and its effect on glucose metabolism in a large non-diabetic population.

Methods

We examined 184 non-diabetic twins with gold-standard techniques including the euglycaemic–hyperinsulinaemic clamp. Insulin signalling was evaluated at three key levels, i.e. the insulin receptor, IRS-1 and V-akt murine thymoma viral oncogene (Akt) levels, employing kinase assays and phospho-specific western blotting.

Results

Proximal insulin signalling was not associated with obesity, age or sex. However, birthweight was positively associated with IRS-1-associated phosphoinositide 3-kinase (PI3K; IRS-1-PI3K) activity (p = 0.04); maximal aerobic capacity \( \left( {\mathop {V}\limits^\cdot {{\hbox{O}}_{\rm{2max}}}} \right) \), paradoxically, was negatively associated with IRS-1-PI3K (p = 0.02) and Akt2 activity (p = 0.01). Additionally, we found low heritability estimates for most measures of insulin signalling activity. Glucose disposal was positively associated with Akt-308 phosphorylation (p < 0.001) and Akt2 activity (p = 0.05), but not with insulin receptor tyrosine kinase or IRS-1-PI3K activity.

Conclusions/interpretation

With the exception of birthweight, ‘classical’ modifiers of insulin action, including genetics, age, sex, obesity and \( \mathop {V}\limits^\cdot {{\hbox{O}}_{\rm{2max}}} \), do not seem to mediate their most central effects on whole-body insulin sensitivity through modulation of proximal insulin signalling in skeletal muscle. We also demonstrated an association between Akt activity and in vivo insulin sensitivity, suggesting a role of Akt in control of in vivo insulin resistance and potentially in type 2 diabetes.

Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed

Perseghin G, Price TB, Petersen KF et al (1996) Increased glucose transport–phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335:1357–1362CrossRefPubMed

Rothman DL, Magnusson I, Cline G et al (1995) Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 92:983–987CrossRefPubMed

Hojlund K, Staehr P, Hansen BF et al (2003) Increased phosphorylation of skeletal muscle glycogen synthase at NH₂-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes 52:1393–1402CrossRefPubMed

Hojlund K, Birk JB, Klein DK et al (2009) Dysregulation of glycogen synthase COOH- and NH₂-terminal phosphorylation by insulin in obesity and type 2 diabetes mellitus. J Clin Endocrinol Metab 94:4547–4556CrossRefPubMed

Poulsen P, Wojtaszewski JF, Richter EA, Beck-Nielsen H, Vaag A (2007) Low birth weight and zygosity status is associated with defective muscle glycogen and glycogen synthase regulation in elderly twins. Diabetes 56:2710–2714CrossRefPubMed

Price TB, Perseghin G, Duleba A et al (1996) NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise. Proc Natl Acad Sci U S A 93:5329–5334CrossRefPubMed

Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806CrossRefPubMed

Bouzakri K, Zachrisson A, Al-Khalili L et al (2006) siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4:89–96CrossRefPubMed

10.

Bjornholm M, Zierath JR (2005) Insulin signal transduction in human skeletal muscle: identifying the defects in type II diabetes. Biochem Soc Trans 33:354–357CrossRefPubMed

11.

Cusi K, Maezono K, Osman A et al (2000) Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105:311–320CrossRefPubMed

12.

Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95:2195–2204CrossRefPubMed

13.

Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, Wallberg-Henriksson H (2005) Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 54:1692–1697CrossRefPubMed

14.

Krook A, Bjornholm M, Galuska D et al (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49:284–292CrossRefPubMed

15.

Hojlund K, Glintborg D, Andersen NR et al (2008) Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 57:357–366CrossRefPubMed

16.

Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA (2005) Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48:547–552CrossRefPubMed

17.

Jensen CB, Martin-Gronert MS, Storgaard H, Madsbad S, Vaag A, Ozanne SE (2008) Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight. PLoS ONE 3:e3738CrossRefPubMed

18.

Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W et al (2004) Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects. Metabolism 53:1233–1242CrossRefPubMed

19.

Belfort R, Mandarino L, Kashyap S et al (2005) Dose–response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54:1640–1648CrossRefPubMed

20.

Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK (2005) Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54:2939–2945CrossRefPubMed

21.

Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176CrossRefPubMed

22.

Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275–283CrossRefPubMed

23.

Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561–572CrossRefPubMed

24.

Grunnet L, Poulsen P, Klarlund PB, Mandrup-Poulsen T, Vaag A (2006) Plasma cytokine levels in young and elderly twins: genes vs environment and relation to in vivo insulin action. Diabetologia 49:343–350CrossRefPubMed

25.

Poulsen P, Levin K, Beck-Nielsen H, Vaag A (2002) Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia 45:1649–1657CrossRefPubMed

26.

Gabir MM, Hanson RL, Dabelea D et al (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23:1108–1112CrossRefPubMed

27.

Poulsen P, Vaag A (2006) The intrauterine environment as reflected by birth size and twin and zygosity status influences insulin action and intracellular glucose metabolism in an age- or time-dependent manner. Diabetes 55:1819–1825CrossRefPubMed

28.

Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420–430CrossRefPubMed

29.

Poulsen P, Wojtaszewski JF, Petersen I et al (2005) Impact of genetic vs environmental factors on the control of muscle glycogen synthase activation in twins. Diabetes 54:1289–1296CrossRefPubMed

30.

Wojtaszewski JF, Hansen BF, Kiens B, Richter EA (1997) Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes 46:1775–1781CrossRefPubMed

31.

Hojlund K, Wojtaszewski JF, Birk J, Hansen BF, Vestergaard H, Beck-Nielsen H (2006) Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene. Diabetologia 49:1827–1837CrossRefPubMed

32.

Monrad RN, Grunnet LG, Rasmussen EL, Malis C, Vaag A, Poulsen P (2009) Age-dependent nongenetic influences of birth weight and adult body fat on insulin sensitivity in twins. J Clin Endocrinol Metab 94:2394–2399CrossRefPubMed

33.

Friedrichsen M, Ribel-Madsen R, Wojtaszewski J et al (2010) Dissociation between skeletal muscle inhibitor-kappaB kinase/nuclear factor-kappaB pathway activity and insulin sensitivity in nondiabetic twins. J Clin Endocrinol Metab 95:414–421CrossRefPubMed

34.

Kemppainen J, Tsuchida H, Stolen K et al (2003) Insulin signalling and resistance in patients with chronic heart failure. J Physiol 550:305–315CrossRefPubMed

35.

Haugaard SB, Andersen O, Madsbad S et al (2005) Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy. Diabetes 54:3474–3483CrossRefPubMed

36.

Yki-Jarvinen H (1984) Sex and insulin sensitivity. Metabolism 33:1011–1015CrossRefPubMed

37.

DeFronzo RA (1981) Glucose intolerance and aging. Diabetes Care 4:493–501CrossRefPubMed

38.

Hoeg L, Roepstorff C, Thiele M, Richter EA, Wojtaszewski JF, Kiens B (2009) Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling. J Appl Physiol 107:824–831CrossRefPubMed

39.

Sriwijitkamol A, Christ-Roberts C, Berria R et al (2006) Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 55:760–767CrossRefPubMed

40.

Kirwan JP, del Aguila LF, Hernandez JM et al (2000) Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol 88:797–803PubMed

41.

Frosig C, Rose AJ, Treebak JT, Kiens B, Richter EA, Wojtaszewski JF (2007) Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Diabetes 56:2093–2102CrossRefPubMed

42.

Hegarty BD, Turner N, Cooney GJ, Kraegen EW (2009) Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase. Acta Physiol (Oxf) 196:129–145CrossRef

43.

Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB (1999) Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104:733–741CrossRefPubMed

44.

Farese RV (2002) Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol Endocrinol Metab 283:E1–E11PubMed

45.

Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol 165:849–857CrossRefPubMed

46.

Rung J, Cauchi S, Albrechtsen A et al (2009) Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 10:1110–1115CrossRef

47.

Vaag A, Poulsen P (2007) Twins in metabolic and diabetes research: what do they tell us? Curr Opin Clin Nutr Metab Care 10:591–596CrossRefPubMed

48.

Bjornholm M, Kawano Y, Lehtihet M, Zierath JR (1997) Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46:524–527CrossRefPubMed

49.

Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight. J Clin Endocrinol Metab 88:1252–1257CrossRefPubMed

50.

Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ (2001) Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276:38349–38352CrossRefPubMed

51.

Cho H, Mu J, Kim JK et al (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292:1728–1731CrossRefPubMed

52.

Cozzone D, Frojdo S, Disse E et al (2008) Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients. Diabetologia 51:512–521CrossRefPubMed

Titel: Differential aetiology and impact of phosphoinositide 3-kinase (PI3K) and Akt signalling in skeletal muscle on in vivo insulin action
verfasst von: M. Friedrichsen
P. Poulsen
E. A. Richter
B. F. Hansen
J. B. Birk
R. Ribel-Madsen
K. Stender-Petersen
E. Nilsson
H. Beck-Nielsen
A. Vaag
J. F. P. Wojtaszewski
Publikationsdatum: 01.09.2010
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 9/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-010-1795-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2010

ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice

Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy

The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion

Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations

Proteinuria modifies the effects of physical activity on total and cardiovascular disease mortality rates in patients with type 2 diabetes